GlassScriptPhysician profile
Alice N Bolick
NPI 1922443167
$1,473.04
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $519 · 2022: $604 · 2023: $278 · 2024: $72.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $350.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $346.00 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $140.10 | 2021-2023 | Relistor |
| Nevro Corp. | $133.83 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $125.41 | 2021 | |
| Nalu Medical, INC. | $90.08 | 2022 | |
| Collegium Pharmaceutical, INC. | $87.78 | 2021-2022 | |
| Grt US Holding, INC. | $77.08 | 2022 | |
| Almatica Pharma LLC | $52.01 | 2021 | |
| Ibsa Pharma INC. | $51.82 | 2021-2022 | |
| Horizon Therapeutics Plc | $48.96 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $47.31 | 2022 | |
| Redhill Biopharma INC. | $44.86 | 2021 | |
| Boston Scientific Corporation | $28.63 | 2023 | |
| Forte Bio-Pharma LLC | $28.13 | 2021-2024 | Prolate, Nalocet |
| Pacira Pharmaceuticals Incorporated | $27.04 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $25.69 | 2023 | Proclaim |
| Relievant Medsystems, INC. | $21.64 | 2022 | |
| Bioventus LLC | $19.17 | 2021 | |
| Vertos Medical, INC. | $19.04 | 2022 | |
| Pfizer INC. | $18.08 | 2023 | |
| Scilex Pharmaceuticals INC. | $14.15 | 2021 | |
| Electronic Waveform Lab, INC. | $13.38 | 2021-2022 | |
| Hikma Pharmaceuticals USA | $12.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Bolick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.